Lauren Skyles
Family · Bridgeton, MONPI 1811406242
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 124 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,418 and has fallen 92.3% since, to $110 in 2025.
Across 124 payments — averaging $14.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$257
- Lilly USA, LLC$157
- E.r. Squibb & Sons, L.L.C.$145
- Biohaven Pharmaceuticals, Inc.$142
- Takeda Pharmaceuticals U.S.A., Inc.$134
- Novo Nordisk$118
- plus $855 from 22 others
What the payments were for
- Food & beverage$1,809100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 15 | $257 |
| Lilly USA, LLC | 9 | $157 |
| E.r. Squibb & Sons, L.L.C. | 9 | $145 |
| Biohaven Pharmaceuticals, Inc. | 12 | $142 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $134 |
| Novo Nordisk | 11 | $118 |
| Pfizer | 7 | $106 |
| Boehringer Ingelheim | 7 | $99 |
| Amarin Pharma, Inc. | 7 | $91 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $68 |
| Acella Pharmaceuticals, LLC | 3 | $64 |
| Optinose US, Inc. | 3 | $51 |
| GSK | 4 | $49 |
| Daiichi Sankyo Inc. | 3 | $46 |
| Merck | 3 | $44 |
| Sanofi-aventis U.S. LLC | 1 | $29 |
| Bayer | 2 | $27 |
| Paratek Pharmaceuticals, Inc. | 2 | $25 |
| Dexcom, Inc. | 2 | $25 |
| Acerus Pharmaceuticals Corporation | 1 | $19 |
| AstraZeneca | 1 | $18 |
| Gilead | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
| Alfasigma USA, Inc. | 1 | $14 |
| Amgen | 1 | $13 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Esperion Therapeutics, Inc. | 1 | $12 |
| Teva Pharmaceuticals USA, Inc. | 1 | $11 |
How this compares
$1,809 in reported general payments places this provider in the 75th percentile of 3,812 family providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 12 | $772 |
| Zolpidem Tartrate | 13 | $65 |
| Diazepam | 13 | $32 |
Paid to pharmacies, not to this prescriber.
Other family in Bridgeton
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
- Laura HedigerSpringfield$71K
- Rebecca SeabaughSaint Louis$68K
- Jennifer GriggColumbia$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.